These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37300942)

  • 61. Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy.
    Yasaswi PS; Shetty K; Yadav KS
    J Control Release; 2021 Aug; 336():549-571. PubMed ID: 34229001
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy.
    Rehman FU; Liu Y; Yang Q; Yang H; Liu R; Zhang D; Muhammad P; Liu Y; Hanif S; Ismail M; Zheng M; Shi B
    J Control Release; 2022 May; 345():696-708. PubMed ID: 35341901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent.
    Uram Ł; Markowicz J; Misiorek M; Filipowicz-Rachwał A; Wołowiec S; Wałajtys-Rode E
    Eur J Pharm Sci; 2020 Sep; 152():105439. PubMed ID: 32615261
    [TBL] [Abstract][Full Text] [Related]  

  • 64. LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
    Cheng M; Wang Q; Chen L; Zhao D; Tang J; Xu J; He Z
    Hum Pathol; 2022 May; 123():59-73. PubMed ID: 35219686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
    Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
    BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
    Tomar MS; Kumar A; Srivastava C; Shrivastava A
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188616. PubMed ID: 34419533
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
    Zhao M; Bozzato E; Joudiou N; Ghiassinejad S; Danhier F; Gallez B; Préat V
    J Control Release; 2019 Sep; 309():72-81. PubMed ID: 31306678
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma.
    Emamgholizadeh Minaei S; Khoei S; Khoee S; Karimi MR
    Int J Biochem Cell Biol; 2019 Mar; 108():72-83. PubMed ID: 30660689
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of encapsulated gas on stability of lipid-based microbubbles and ultrasound-triggered drug delivery.
    Omata D; Maruyama T; Unga J; Hagiwara F; Munakata L; Kageyama S; Shima T; Suzuki Y; Maruyama K; Suzuki R
    J Control Release; 2019 Oct; 311-312():65-73. PubMed ID: 31461665
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Buoyancy-activated cell sorting using targeted biotinylated albumin microbubbles.
    Liou YR; Wang YH; Lee CY; Li PC
    PLoS One; 2015; 10(5):e0125036. PubMed ID: 25993512
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study.
    Yu Y; Wang A; Wang S; Sun Y; Chu L; Zhou L; Yang X; Liu X; Sha C; Sun K; Xu L
    Mol Pharm; 2022 Apr; 19(4):1219-1229. PubMed ID: 35262365
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interaction Between Near-Infrared Radiation and Temozolomide in a Glioblastoma Multiform Cell Line: A Treatment Strategy?
    Marinho MAG; da Silva Marques M; Lettnin AP; de Souza Votto AP; de Moraes Vaz Batista Filgueira D; Horn AP
    Cell Mol Neurobiol; 2021 Jan; 41(1):91-104. PubMed ID: 32236902
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study.
    Yu Y; Wang L; Han J; Wang A; Chu L; Xi X; Kan R; Sha C; Sun K
    J Pharm Sci; 2021 Oct; 110(10):3431-3438. PubMed ID: 34147518
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The antagonistic effects of temozolomide and trichostatin a combination on MGMT and DNA mismatch repair pathways in Glioblastoma.
    Güven M; Taşpınar F; Denizler-Ebiri FN; Castresana JS; Taşpınar M
    Med Oncol; 2023 Jul; 40(8):223. PubMed ID: 37403006
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
    Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
    Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A natural protein based platform for the delivery of Temozolomide acid to glioma cells.
    Helal DO; Rouatbi N; Han S; Tzu-Wen Wang J; Walters AA; Abdel-Mottaleb MMA; Kamel AO; Geneidi AS; Awad GAS; Al-Jamal KT
    Eur J Pharm Biopharm; 2021 Dec; 169():297-308. PubMed ID: 34678408
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.
    Gilbert CA; Daou MC; Moser RP; Ross AH
    Cancer Res; 2010 Sep; 70(17):6870-9. PubMed ID: 20736377
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.